Carl W. Ehmann
Director/Miembro de la Junta en MUSC Foundation for Research Development .
Perfil
Carl W.
Ehmann is currently the Director at MUSC Foundation for Research Development and the Treasurer & Director at Guadalupe Center, Inc. Previously, he worked as a Director at Barrier Therapeutics, Inc. from 2004 to 2008, Director-Clinical Research & Dermatology at Hoffman-LaRoche F & Co. AG, VP-Pharmaceutical Research & Development at Bristol Myers Squibb Co., and Executive VP, Head-Global Research & Development at Johnson & Johnson.
He received his undergraduate and doctorate degrees from State University of New York at Buffalo.
Cargos activos de Carl W. Ehmann
| Empresas | Cargo | Inicio |
|---|---|---|
| MUSC Foundation for Research Development | Director/Miembro de la Junta | - |
Guadalupe Center, Inc.
 Guadalupe Center, Inc. Services to the Health IndustryHealth Services Guadalupe Center, Inc. provides educational, social, and other support programs and resources for the children and families of Immokalee. The company was founded in 1982 and is headquartered in Immokalee, FL. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Carl W. Ehmann.
| Empresas | Cargo | Fin |
|---|---|---|
Barrier Therapeutics, Inc.
 Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | Director/Miembro de la Junta | 04/08/2008 |
| JOHNSON & JOHNSON | Director Técnico/Científico/I+D | - |
| BRISTOL-MYERS SQUIBB COMPANY | Director Técnico/Científico/I+D | - |
Hoffman-LaRoche F & Co. AG
 Hoffman-LaRoche F & Co. AG Miscellaneous Commercial ServicesCommercial Services Hoffman-LaRoche F & Co. AG is a Swiss company. | Director Técnico/Científico/I+D | - |
Formación de Carl W. Ehmann.
| State University of New York at Buffalo | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| Empresas privadas | 4 |
|---|---|
Barrier Therapeutics, Inc.
Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | Health Technology |
| MUSC Foundation for Research Development | |
Hoffman-LaRoche F & Co. AG
Hoffman-LaRoche F & Co. AG Miscellaneous Commercial ServicesCommercial Services Hoffman-LaRoche F & Co. AG is a Swiss company. | Commercial Services |
Guadalupe Center, Inc.
Guadalupe Center, Inc. Services to the Health IndustryHealth Services Guadalupe Center, Inc. provides educational, social, and other support programs and resources for the children and families of Immokalee. The company was founded in 1982 and is headquartered in Immokalee, FL. | Health Services |
- Bolsa de valores
- Insiders
- Carl W. Ehmann
